# Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

> **NCT00217282** · PHASE2 · COMPLETED · sponsor: **Mt. Sinai Medical Center, Miami** · enrollment: 45 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** oxaliplatin, gemcitabine, bevacizumab

## Key facts

- **NCT ID:** NCT00217282
- **Lead sponsor:** Mt. Sinai Medical Center, Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2007-06
- **Final completion:** 2008-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2008-05-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217282, "Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00217282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*